Invivyd, Inc. - Common Stock (NQ:IVVD)

0.5892 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Invivyd, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

IVVD Stock Earnings: Invivyd Meets EPS for Q1 2024 ↗

May 09, 2024

IVVD stock results show that Invivyd met analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Invivyd Reports First Quarter 2024 Financial Results and Recent Business Highlights

May 09, 2024

From Invivyd

Via GlobeNewswire

Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA Feedback

May 07, 2024

From Invivyd

Via GlobeNewswire

IVVD Stock Earnings: Invivyd Misses EPS for Q4 2023 ↗

March 28, 2024

IVVD stock results show that Invivyd missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Invivyd: Q4 Earnings Insights ↗

March 28, 2024

Via Benzinga

Invivyd to Host Conference Call Discussing First Quarter 2024 Financial Results and Business Highlights

May 02, 2024

From Invivyd

Via GlobeNewswire

Invivyd Announces $20 Million to $25 Million Improvement in Projected 2024 Year-End Cash Position

April 30, 2024

From Invivyd

Via GlobeNewswire

Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™

April 15, 2024

From Invivyd

Via GlobeNewswire

Invivyd Announces CEO Transition

April 12, 2024

Jeremy Gowler appointed Interim CEO

From Invivyd

Via GlobeNewswire

Kura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session ↗

April 05, 2024

U.S. stock futures were higher this morning, with the Dow futures gaining by around 100 points on Friday.

Via Benzinga

Topics Stocks

Invivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 Million

April 04, 2024

From Invivyd

Via GlobeNewswire

Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights

March 28, 2024

From Invivyd

Via GlobeNewswire

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 26, 2024

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81...

Via Benzinga

Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday ↗

March 26, 2024

U.S. stocks were higher, with the Dow Jones index gaining around 50 points on Tuesday.

Via Benzinga

Topics Stocks

Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket ↗

March 26, 2024

Shares of Stoke Therapeutics, Inc. (NASDAQ: STOK) rose sharply in today’s pre-market trading after the company announced Phase 1/2a data supporting the potential for STK-001

Via Benzinga

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 25, 2024

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 25, 2024

Via Benzinga

Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday ↗

March 25, 2024

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday.

Via Benzinga

Topics Stocks

FDA Gives Emergency Use Nod To Invivyd's Antibody To Prevent COVID-19 Infection In Adults, Adolescents With Weak Immune System ↗

March 25, 2024

FDA grants emergency use authorization to Invivyd's Pemgarda (pemivibart), a monoclonal antibody for COVID-19 prevention in immune-compromised adults. Interim trial data revealed.

Via Benzinga

Why Salarius Pharmaceuticals Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket ↗

March 25, 2024

Shares of Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) rose sharply in today’s pre-market trading following fourth-quarter results.

Via Benzinga

Invivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Clinical Trial

March 22, 2024

From Invivyd

Via GlobeNewswire

Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19

March 22, 2024

From Invivyd

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 12, 2024

Via Benzinga

Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

February 12, 2024

Shares of Big Lots, Inc. (NYSE: BIG) fell sharply during Monday’s session after the company reported preliminary fourth-quarter results. Also, Loop Capital downgraded the stock from Hold to Sell and...

Via Benzinga

Invivyd to Participate at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

February 05, 2024

From Invivyd

Via GlobeNewswire

3 Groundbreaking Biotech Stocks to Invest in Now ↗

January 29, 2024

These are several biotech companies for investors seeking unique opportunities for great returns within the industry.

Via InvestorPlace

Apple To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Thursday ↗

January 18, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

January 10, 2024

The biggest pre-market stock movers for Wednesday are ready to go as we break down all of the latest news moving shares today!

Via InvestorPlace

Invivyd Submits Request for Emergency Use Authorization (EUA) to U.S. FDA for VYD222 for the Pre-exposure Prevention of COVID-19 in Immunocompromised Adults and Adolescents

January 03, 2024

From Invivyd

Via GlobeNewswire

Invivyd Stock More Than Doubled Last Week. Is It Too Late to Buy? ↗

December 23, 2023

The clinical-stage biotech delivered positive trial results for its new COVID-19 preventative antibody treatment.

Via The Motley Fool

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.